News and Announcements
iFAST Annual Update 2016; Launched FSMOne, Continued Efforts in China, Hong Kong and Malaysia
- Published January 31, 2017 10:53AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
iFAST Corporation Ltd.: Leading investment products distribution platform in Asia continues to strengthen investment and fintech capabilities in 2016
- Launched FSMOne (www.fsmone.com) in Dec 2016, giving investors community in Singapore the ability to invest seamlessly in multiple investment products including funds, robo-advisory portfolios, bonds, stocks, ETFs and insurance products, in one account
- Completed acquisition of a stockbroker in Hong Kong in Jan 2016 and launched insurance products on Fundsupermart Malaysia in July 2016
- Continuing efforts in China to build team of wealth advisers, as part of ‘platform-cum-IFA incubator’ strategy, and signing up additional Chinese companies to tap on the platform’s fintech investment capabilities
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
